08:36 AM EDT, 07/09/2025 (MT Newswires) -- Evolus ( EOLS ) said Wednesday that it has partnered with Symatese to distribute its Botox product Nuceiva in France.

Financial terms were not disclosed.

Nuceiva, also called botulinum toxin type A, has been approved by the European Commission for the temporary improvement in the appearance of moderate to severe vertical lines between the eyebrows when the severity of the above facial lines has an important psychological impact in adults below 65 years old, the company said.

Nuceiva is licensed in the US under the brand name Jeuveau, the company said.